跳至主要内容
临床试验/NCT06680167
NCT06680167进行中(未招募)1 期

A Comparative Study Between Hyperbaric Prilocaine 2% Versus Hyperbaric Bupivacaine 0.5% For Intrathecal Anesthesia in Caesarean Section

Sohag University1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2024年10月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
142
试验地点
1
主要终点
Measurment of onset time and duration of sensory block of Hyperbaric Bupivacaine 0.5% and Hyperbaric Prilocaine 2% using pinprick sensation test in women undergoing caesarean section

研究概览

简要总结

Comparison between effects of hyperbaric bupivacaine 0.5% vs Hyperbaric prilocaine 2% in spinal anesthesia of women undergoing elective caesarean section such as onset time of sensory and motor block, duration of sensory and motor block, effects of maternal hemodynamics and expected side effects .

详细描述

Patients will be randomly allocated into two groups:

  1. Prilocaine Group (Group A):
  • Patients will receive 60 mg of hyperbaric prilocaine 2% intrathecally.
  • The anesthetic solution will be injected intrathecally using a 25 Gauge spinal needle, with the patient in a sitting position (midline or paramedian technique).
  • The injection will be performed at the L3-L4 or L4-L5 interspace.
  1. Bupivacaine Group (Group B):
  • Patients will receive 12.5 mg of hyperbaric bupivacaine 0.5% intrathecally.
  • The anesthetic solution will be injected intrathecally using a 25 Gauge spinal needle, with the patient in a sitting position (midline or paramedian technique) .
  • The injection will be performed at the L3-L4 or L4-L5 interspace.

Procedure Details:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18-45 years.
  • Patients with uncomplicated pregnancies.
  • American society of anesthesiologist (ASA) physical status I or II.
  • Height between 155 cm and 175 cm.
  • Written informed consent provided. -

排除标准

  • Patients with known allergies to local anesthetics.
  • Contraindications to intrathecal anesthesia (e.g., infection at the injection site and coagulopathy).
  • Severe preeclampsia or eclampsia.
  • Presence of significant comorbidities (e.g., uncontrolled diabetes, hypertension, renal or hepatic dysfunction).
  • History of spinal surgery or significant spinal deformity.
  • Patients who refuse to participate in the study -

研究组 & 干预措施

patients of group A will receive 60mg of hyperbaric prilocaine 2% for spinal anesthesia

Active Comparator

干预措施: spinal anesthesia (hyperbaric Prilocaine 2%) (Drug)

patients of group B will receive 12.5mg heavy bupivacaine for spinal anesthesia

Active Comparator

干预措施: Spinal anesthesia (heavy bupivacaine 0.5%) (Drug)

结局指标

主要结局

Measurment of onset time and duration of sensory block of Hyperbaric Bupivacaine 0.5% and Hyperbaric Prilocaine 2% using pinprick sensation test in women undergoing caesarean section

时间窗: 12 HOURS

2- Measurment of onset time and duration of motor block of Hyperbaric Bupivacaine 0.5% and Hyperbaric Prilocaine 2% using modified bromage scale in women undergoing caesarean section

时间窗: 12 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mostafa Mohamed Abdelgaber

A Comparative Study between Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% For Intrathecal Anesthesia in Caesarean Section

Sohag University

研究点 (1)

Loading locations...

相似试验

Hyperbaric Prilocaine 2% vs Hyperbaric Bupivacaine... | 临床试验